相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
Theresa L. Whiteside
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry
Hatem Soliman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma
Jocelyne Jacquemier et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Xi Chen et al.
CANCER INFORMATICS (2012)
A gene expression signature identifies two prognostic subgroups of basal breast cancer
Renaud Sabatier et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
L-Kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species
Hyunkeun Song et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
Lisa K. Koch et al.
BLOOD (2009)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo
TM Bauer et al.
TRANSPLANT INTERNATIONAL (2005)
Interplay of natural killer cells and their receptors with the adaptive immune response
DH Raulet
NATURE IMMUNOLOGY (2004)
Tissue and serum MUC1 mucin detection in breast cancer patients
MV Croce et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Preferential apoptosis of CD56(dim) natural killer cell subset in patients with cancer
T Bauernhofer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
分享论文
